GB859609A - Improvements in or relating to lyophilized protein hydrolysates - Google Patents
Improvements in or relating to lyophilized protein hydrolysatesInfo
- Publication number
- GB859609A GB859609A GB2073458A GB2073458A GB859609A GB 859609 A GB859609 A GB 859609A GB 2073458 A GB2073458 A GB 2073458A GB 2073458 A GB2073458 A GB 2073458A GB 859609 A GB859609 A GB 859609A
- Authority
- GB
- United Kingdom
- Prior art keywords
- gelatin
- hydrolysate
- aqueous solution
- lyophiliser
- protein hydrolysate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Non-gelatinous protein hydrolysate suitable for parenteral use is lyophilized in aqueous solution containing, in addition to the protein hydrolysate, a gelatin hydrolysate having a gel point of 15 to 20 DEG C. in 26 to 35% aqueous solution and being present in a ratio of 1 to 2 parts of gelatin hydrolysate to 9 parts of the non-gelatinous protein hydrolysate; it is stated that the foaming problem normally encountered does not become apparent to any appreciable extent when the partially hydrolysed gelatin is included. The gelatin hydrolysate may be made by hydrolysing an aqueous solution of gelatin for three hours at approximately 250 DEG F. and 15 lbs. per sq. inch pressure. According to an example, to 1,470 ml. of 23% casein hydrolysate in which 69% of the total nitrogen was in the form of a -amino nitrogen, there was added 188 ml. of hydrolysed gelatin prepared as described above and containing 32% solids. Vitamins &c., dextrose and sodium ethyl mercurithiosalicylate were added and the total volume of the solution was brought up to 3,08 litres with warm pyrogenfree distilled water. After filtering, 77 ml. portions of the solution filled into 250 ml. brown-glass bottles were frozen at -60 DEG F. and then placed in a lyophiliser, the pressure being decreased to 50-150 microms. The bottles were finally removed from the lyophiliser and aseptically stoppered. The product, which contained less than 5% of moisture, reconstituted readily with pyrogen-free distilled water. Other examples are concerned with lyophilising bovine plasma and fibrin hydrolysates.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2073458A GB859609A (en) | 1958-06-27 | 1958-06-27 | Improvements in or relating to lyophilized protein hydrolysates |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2073458A GB859609A (en) | 1958-06-27 | 1958-06-27 | Improvements in or relating to lyophilized protein hydrolysates |
Publications (1)
Publication Number | Publication Date |
---|---|
GB859609A true GB859609A (en) | 1961-01-25 |
Family
ID=10150764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2073458A Expired GB859609A (en) | 1958-06-27 | 1958-06-27 | Improvements in or relating to lyophilized protein hydrolysates |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB859609A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017180648A1 (en) * | 2016-04-11 | 2017-10-19 | Cook Biotech Incorporated | Fibrin and/or dialdehyde starch hydrolysate materials, and preparation and use thereof |
US11604026B2 (en) | 2019-03-14 | 2023-03-14 | Terumo Bct Biotechnologies, Llc | Lyophilization loading tray assembly and system |
US11634257B2 (en) | 2017-10-09 | 2023-04-25 | Terumo Bct Biotechnologies, Llc | Lyophilization container and method of using same |
-
1958
- 1958-06-27 GB GB2073458A patent/GB859609A/en not_active Expired
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017180648A1 (en) * | 2016-04-11 | 2017-10-19 | Cook Biotech Incorporated | Fibrin and/or dialdehyde starch hydrolysate materials, and preparation and use thereof |
US11634257B2 (en) | 2017-10-09 | 2023-04-25 | Terumo Bct Biotechnologies, Llc | Lyophilization container and method of using same |
US11604026B2 (en) | 2019-03-14 | 2023-03-14 | Terumo Bct Biotechnologies, Llc | Lyophilization loading tray assembly and system |
US11609042B2 (en) | 2019-03-14 | 2023-03-21 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
US11609043B2 (en) | 2019-03-14 | 2023-03-21 | Terumo Bct Biotechnologies, Llc | Lyophilization container fill fixture, system and method of use |
US11740019B2 (en) | 2019-03-14 | 2023-08-29 | Terumo Bct Biotechnologies, Llc | Lyophilization loading tray assembly and system |
US11747082B2 (en) | 2019-03-14 | 2023-09-05 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
US11815311B2 (en) | 2019-03-14 | 2023-11-14 | Terumo Bct Biotechnologies, Llc | Lyophilization container fill fixture, system and method of use |
US11994343B2 (en) | 2019-03-14 | 2024-05-28 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1363949A (en) | Acidic beverage having polypeptides from defatted protein | |
GB1319390A (en) | Process for sterilising contact lenses | |
GB1532720A (en) | Blood circulatory assist device | |
ES426678A1 (en) | Fermented soya protein | |
GB859609A (en) | Improvements in or relating to lyophilized protein hydrolysates | |
IE791033L (en) | Stabilised milk compositions | |
ES8102805A1 (en) | Stabilization of capsular polysaccharides. | |
GB1189935A (en) | Dried Stable Anti-Tumour Preparations and a process for preparing the same | |
GB856558A (en) | Improvements in or relating to packing | |
US3523871A (en) | Stabilization of catalase | |
GB858783A (en) | Improvements in or relating to vitamin b compositions | |
GB1330230A (en) | Amylase inhibitor processes for its production and compositions containing it | |
GB1155793A (en) | Process for the Recovery and Purification of Lysozyme | |
GB1382008A (en) | Fungicidal and/or bacterial composition and method | |
GB1423913A (en) | Purification of orgotein | |
ES389894A1 (en) | Manufacture of natural amino acid mixtures from protein materials | |
Wagreich et al. | The influence of amino acids on the reactivation of yeast invertase | |
US2490911A (en) | Process for purifying antifibrinolysin | |
FR2055537A5 (en) | Separation of pure proteins | |
GB1103683A (en) | Process for the production of a respiration-stimulating preparation | |
GB1285857A (en) | Purification of gamma globulin | |
GB944428A (en) | Cobalamin derivatives | |
GB1417277A (en) | Fibrinolytic substances | |
GB1256020A (en) | Enzyme purification | |
GB892360A (en) | A process for the production of urea having a low water and biuret content |